Cargando…
TRAM-34, a Putatively Selective Blocker of Intermediate-Conductance, Calcium-Activated Potassium Channels, Inhibits Cytochrome P450 Activity
TRAM-34, a clotrimazole analog characterized as a potent and selective inhibitor of intermediate-conductance, calcium-activated K(+) (IK(Ca)) channels, has been used extensively in vitro and in vivo to study the biological roles of these channels. The major advantage of TRAM-34 over clotrimazole is...
Autores principales: | Agarwal, Jay J., Zhu, Yi, Zhang, Qing-Yu, Mongin, Alexander A., Hough, Lindsay B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3646888/ https://www.ncbi.nlm.nih.gov/pubmed/23667566 http://dx.doi.org/10.1371/journal.pone.0063028 |
Ejemplares similares
-
The KCa3.1 blocker TRAM34 reverses renal damage in a mouse model of established diabetic nephropathy
por: Huang, Chunling, et al.
Publicado: (2018) -
General Sensitization of Melanoma Cells for TRAIL-Induced Apoptosis by the Potassium Channel Inhibitor TRAM-34 Depends on Release of SMAC
por: Quast, Sandra-Annika, et al.
Publicado: (2012) -
Critical role of reactive oxygen species (ROS) for synergistic enhancement of apoptosis by vemurafenib and the potassium channel inhibitor TRAM-34 in melanoma cells
por: Bauer, Daniel, et al.
Publicado: (2017) -
Opioids Activate Brain Analgesic Circuits Through Cytochrome P450/Epoxygenase Signaling
por: Conroy, Jennie L., et al.
Publicado: (2010) -
Succinic acid inhibits the activity of cytochrome P450 (CYP450) enzymes
por: Wang, Hao, et al.
Publicado: (2020)